Skip to main content
. 2024 Dec 13;23(1):e12601. doi: 10.1002/rmb2.12601

TABLE 13.

The relationship between the GnRH antagonist protocol, position (θ) of the meiotic spindle relative to the polar body, and outcomes.

Outcome θ = 0° 0° < θ ≤ 30° 30° < θ ≤ 60° 60° < θ ≤ 90° 90° < θ ≤ 180°
Female age, mean years ± SD a 36.7 ± 5.1 37.0 ± 5.1 37.3 ± 5.4 37.7 ± 5.0 37.6 ± 5.5
n (%) n (%) n (%) n (%) n (%)
ICSI b
MII oocytes c 679 389 224 104 36
2PN2PB oocytes 521 (76.7) 313 (80.5) 171 (76.3) 80 (76.9) 26 (72.2)
1PN oocytes 15 (2.2) 6 (1.5) 6 (2.7) 5 (4.8) 0 (0.0)
Multi‐PN oocytes 19 (2.8) 15 (3.9) 10 (4.5) 5 (4.8) 2 (5.6)
No‐PN oocytes 25 (3.7) 15 (3.9) 11 (4.9) 4 (3.8) 0 (0.0)
Unfertilized oocytes 64 (9.4) 19 (4.9) 12 (5.4) 5 (4.8) 0 (0.0)
Broken oocytes 35 (5.2) 21 (5.4) 14 (6.3) 5 (4.8) 8 (22.2)**,§,†,#
Embryo development
Cultured 2PN2PB d 403 237 139 55 19
Blastocysts 267 (66.3) 156 (65.8) 88 (63.3) 39 (70.9) 12 (63.2)
Pregnancy, live birth, and miscarriage
Blastocyst transfer cycles 121 47 42 17 3
hCG‐positive 39 (32.2) 14 (29.8) 14 (33.3) 5 (29.4) 0 (0.0)
GS‐positive 28 (23.1) 13 (27.7) 10 (23.8) 2 (11.8)
FHM‐positive 25 (20.7) 10 (21.3) 10 (23.8) 2 (11.8)
LB/OP 23 (19.0) 9 (19.1) 10 (23.8) 1 (5.9)
Miscarriage e 5 (17.9) 4 (30.8) 0 (0.0) 1 (50.0)

Note: Holm test used to determine significance.

Abbreviations: FHM, fetal heart movement; GnRH, gonadotropin‐releasing hormone; GS, gestational sac; hCG, human chorionic gonadotropin; ICSI, intracytoplasmic sperm injection; LB/OP, live birth, or ongoing pregnancy; MII, metaphase II; PB, polar body; PN, pronuclei.

**p < 0.01, each group vs. θ = 0°. § p < 0.05, each group vs. 0° < θ ≤ 30°. p < 0.05, each group vs. 30° < θ ≤ 60°. # p < 0.05, each group vs. 60° < θ ≤ 90°.

a

Steel–Dwass test.

b

ICSI cycles using frozen‐thawed spermatozoa, spermatozoa retrieved by testicular sperm extraction, or oocytes that were artificially activated were excluded from the analysis.

c

Oocyte with spindle within ooplasm.

d

2PN2PB oocytes cultured until confirmation of blastocyst formation.

e

Rate of miscarriage = Patients with miscarriage (n)/GS‐positive patients (n) × 100.